Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate Cancer
The Clinical Utility of Measuring Total PSA, PSA Density, gamma-Seminoprotein and gamma-Seminoprotein/Total PSA in Prostate Cancer Prediction
Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?
Usefulness of PSA Density and PSA Excess in the Differential Diagnosis between Prostate Cancer and Benign Prostatic Hypertrophy
Measurement of PSA density by 3 imaging modalities and its correlation with the PSA density of radical prostatectomy specimen
PSA TEST CAN FIND AGGRESSIVE PROSTATE CANCERS EARLY
The Value of PSA, Free-to-total PSA Ratio and PSA Density in the Prediction of Pathologic Stage for Clinically Localized Prostate Cancer
Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml
Prostate-specific antigen: current status
